Dynavax Common Stock Total Equity from 2010 to 2024

DVAX Stock  USD 12.91  0.25  1.97%   
Dynavax Technologies Common Stock Total Equity yearly trend continues to be fairly stable with very little volatility. Common Stock Total Equity will likely drop to about 85 K in 2024. Common Stock Total Equity is the total value of common stock equity held by shareholders, representing their ownership interest in the company. View All Fundamentals
 
Common Stock Total Equity  
First Reported
2003-12-31
Previous Quarter
128 K
Current Value
128 K
Quarterly Volatility
63.6 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Dynavax Technologies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dynavax Technologies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 3.7 M, Interest Expense of 4 M or Other Operating Expenses of 282.8 M, as well as many indicators such as Price To Sales Ratio of 7.36, Dividend Yield of 0.0 or PTB Ratio of 4.48. Dynavax financial statements analysis is a perfect complement when working with Dynavax Technologies Valuation or Volatility modules.
  
Check out the analysis of Dynavax Technologies Correlation against competitors.
For more information on how to buy Dynavax Stock please use our How to Invest in Dynavax Technologies guide.

Latest Dynavax Technologies' Common Stock Total Equity Growth Pattern

Below is the plot of the Common Stock Total Equity of Dynavax Technologies over the last few years. It is the total value of common stock equity held by shareholders, representing their ownership interest in the company. Dynavax Technologies' Common Stock Total Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dynavax Technologies' overall financial position and show how it may be relating to other accounts over time.
Common Stock Total Equity10 Years Trend
Very volatile
   Common Stock Total Equity   
       Timeline  

Dynavax Common Stock Total Equity Regression Statistics

Arithmetic Mean100,548
Geometric Mean69,305
Coefficient Of Variation68.32
Mean Deviation54,049
Median85,014
Standard Deviation68,691
Sample Variance4.7B
Range261K
R-Value0.02
Mean Square Error5.1B
R-Squared0.0002
Significance0.96
Slope240.36
Total Sum of Squares66.1B

Dynavax Common Stock Total Equity History

202485 K
2023147.2 K
2022128 K
2021123 K
2020110 K
201984 K
201863 K

About Dynavax Technologies Financial Statements

Dynavax Technologies investors use historical fundamental indicators, such as Dynavax Technologies' Common Stock Total Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dynavax Technologies. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Common Stock Total Equity147.2 K85 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Dynavax Stock Analysis

When running Dynavax Technologies' price analysis, check to measure Dynavax Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dynavax Technologies is operating at the current time. Most of Dynavax Technologies' value examination focuses on studying past and present price action to predict the probability of Dynavax Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dynavax Technologies' price. Additionally, you may evaluate how the addition of Dynavax Technologies to your portfolios can decrease your overall portfolio volatility.